Clinical Trial Update: A Clinical Study of HX111 in Patients With Advanced Solid Tumor and Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes HX111 testing in patients with advanced solid tumors and lymphoma, currently in Phase 1/2 and not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumor

Drugs mentioned

• HX111

Snippet

Sponsor: Hanx Biopharmaceuticals (Wuhan) Co., Ltd. | Conditions: Solid Tumor and Lymphoma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING